Steven Leonard Chapman - Nov 1, 2021 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CEO AND PRESIDENT, Director
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Nov 1, 2021
Transactions value $
-$698,626
Form type
4
Date filed
11/1/2021, 09:02 PM
Previous filing
Oct 5, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$9.04K -80 -0.22% $113.01 37K Nov 1, 2021 Direct F1, F2
transaction NTRA Common Stock Sale -$48.3K -420 -1.13% $114.91 36.6K Nov 1, 2021 Direct F1, F3
transaction NTRA Common Stock Sale -$118K -1.02K -2.78% $116.10 35.6K Nov 1, 2021 Direct F1, F4
transaction NTRA Common Stock Options Exercise $28.4K +3.05K +8.58% $9.29* 38.6K Nov 1, 2021 Direct
transaction NTRA Common Stock Options Exercise $42.2K +2.08K +5.39% $20.27 40.7K Nov 1, 2021 Direct
transaction NTRA Common Stock Sale -$22.6K -200 -0.49% $113.01 40.5K Nov 1, 2021 Direct F5
transaction NTRA Common Stock Sale -$127K -1.11K -2.73% $114.73 39.4K Nov 1, 2021 Direct F5, F6
transaction NTRA Common Stock Sale -$393K -3.39K -8.6% $115.99 36K Nov 1, 2021 Direct F5, F7
transaction NTRA Common Stock Sale -$51.3K -440 -1.22% $116.50 35.6K Nov 1, 2021 Direct F5, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Stock Option (right to buy) Options Exercise $0 -3.05K -16.66% $0.00 15.3K Nov 1, 2021 Common Stock 3.05K $9.29 Direct F9
transaction NTRA Stock Option (right to buy) Options Exercise $0 -2.08K -5.55% $0.00 35.4K Nov 1, 2021 Common Stock 2.08K $20.27 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2021,
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.56 to $115.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.60 to $116.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.44 to $115.20 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.45 to $116.44 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.46 to $116.5950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
F10 The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.